Alset Inc. filed a Form 8-K on October 30, 2026, disclosing that it received a Nasdaq deficiency notification on October 28, 2026, stating that its common stock had closed below $1.00 per share for 30 consecutive trading days, placing it out of compliance with the Nasdaq minimum bid price requirement.

Key Highlights

  • Deficiency notice received: Alset Inc. received a notification letter from Nasdaq's Listing Qualifications Department on October 28, 2026.
  • Trigger: The company's common stock closing bid price was below $1.00 for 30 consecutive trading days, failing Nasdaq Marketplace Rule 5550(a)(2).
  • Compliance deadline: The company has 180 calendar days from October 28, 2026, or until April 26, 2027, to regain compliance.
  • Compliance threshold: The stock must close at or above $1.00 per share for a minimum of 10 consecutive business days to satisfy the requirement.
  • Possible extension: If compliance is not achieved by April 26, 2027, the company may be eligible for an additional 180-calendar-day period, subject to meeting other Nasdaq listing standards.
  • Reverse stock split: According to the filing, the company "has previously announced its intent to effect a reverse stock split of the Company's Common Stock by a ratio of 1-for-5" and anticipates announcing timing "in the immediate future."
  • No immediate listing impact: The filing states the notification "has no immediate effect on the listing of the Company's common stock."

Alset Inc. Discloses Nasdaq Bid Price Deficiency and Path to Compliance

Alset Inc. (NASDAQ:AEI), a Texas-incorporated company headquartered in Bethesda, Maryland, disclosed in an October 30, 2026 Form 8-K that it received a formal deficiency letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC. According to the filing, the notification was issued because the closing bid price for the company's common stock remained below $1.00 per share for 30 consecutive trading days, triggering non-compliance with Nasdaq Marketplace Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share.

The filing states that under Nasdaq Marketplace Rule 5810(c)(3)(A), the company has until April 26, 2027, to regain compliance. Compliance can be achieved if the bid price closes at or above $1.00 per share for at least 10 consecutive business days before that deadline, at which point Nasdaq would provide written notification of compliance. The filing notes that the deficiency notice carries no immediate effect on the current listing status of the common stock.

If the company does not meet the threshold by April 26, 2027, the filing explains that it may qualify for an additional 180-calendar-day extension, provided it meets Nasdaq's continued listing requirements for market value of publicly held shares and all other initial listing standards except the bid price requirement, and provides written notice of its intent to cure the deficiency. The filing notes that a reverse stock split at a ratio of 1-for-5 has been previously announced, and that the company "anticipates announcing the timing of such reverse stock split in the immediate future." If Nasdaq staff determine the company cannot cure the deficiency, the filing states the company's securities would be subject to delisting, though the company could appeal that determination.

What Was Disclosed

Alset Inc. reported receiving a Nasdaq minimum bid price deficiency notice on October 28, 2026, citing 30 consecutive trading days below $1.00 per share. The company has until April 26, 2027, to regain compliance and has disclosed a previously announced 1-for-5 reverse stock split as a potential remedy.